Related Experiment Video
Updated: Oct 4, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment
Abdullah Kadir Dolu1, Orhan Karayiğit2, Can Ozkan3
1Department of Cardiology, Izmir Katip Çelebi University Ataturk Education and Research Hospital, Izmir, Turkey.
Insights
The systemic immune-inflammation index (SII) effectively predicts high thrombus burden in ST-elevation myocardial infarction (STEMI) patients. SII demonstrates superior predictive capability compared to neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR).
Area of Science:
- Cardiology
- Immunology
- Biomarkers
Background:
- Intracoronary thrombus burden is a critical factor in ST-elevation myocardial infarction (STEMI).
- Inflammatory markers, including neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), have been investigated as predictors in cardiovascular diseases.
- The systemic immune-inflammation index (SII) is a composite marker reflecting systemic inflammation and immune cell status.
Purpose of the Study:
- To evaluate the relationship between intracoronary thrombus burden and SII in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
- To compare the predictive capacity of SII against NLR and PLR for high thrombus burden in this patient cohort.
Main Methods:
- A total of 425 STEMI patients who underwent PPCI were analyzed.
- Intracoronary thrombus burden was assessed using the Thrombolysis in Myocardial Infarction (TIMI) thrombus classification.
- SII was calculated as platelet count × neutrophil count / lymphocyte count. NLR and PLR were also computed.
Main Results:
- High NLR, PLR, SII, and low left ventricle ejection fraction (LVEF) were identified as independent predictors of high thrombus burden.
- SII values above 812 demonstrated significant predictive power for high thrombus burden (AUC: 0.836).
- The predictive performance of SII was superior to that of NLR (AUC: 0.818) and PLR (AUC: 0.780).
Conclusions:
- The systemic immune-inflammation index (SII) is an independent predictor of high thrombus burden in STEMI patients.
- SII exhibits superior predictive capacity for high thrombus burden compared to NLR and PLR in this population.
- These findings suggest SII could be a valuable biomarker for risk stratification in STEMI patients.
Aim:
This study aimed to evaluate the relationship between intracoronary thrombus burden and systemic immune-inflammation index (SII) and to compare the predictive capacity of SII together with the neutrophil-lymphocyte ratio (NLR), and the platelet-lymphocyte ratio (PLR) in patients with ST-elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PPCI).
Patient & Methods:
A total of 425 patients were included in the study. The clinical, laboratory, and demographic characteristics of the patients were recorded. The thrombus classification "Thrombolysis in myocardial infarction (TIMI)" was used to assess the intracoronary thrombus burden. According to the TIMI thrombus classification, 229 (54%) patients with low thrombus burden (grade 0-3) and 196 (46%) patients with high thrombus burden (grade 4 and 5) were compared. SII was calculated as platelet × neutrophil/lymphocyte counts.
Results:
High NLR (OR: 1.068, 95% CI:1.023-1.404; p = 0.031), PLR(OR: 1.012, 95% CI:1.002-1.018; p = 0.043), SII(OR: 1.325, 95% CI: 1.156-1.879; p = 0.015) and low left ventricle ejection fraction (LVEF) (OR: 0.957, 95% CI:0.924-0.990; p = 0.012) were found to be independent predictors of high thrombus burden. SII values above 812 predicted a high thrombus burden with a sensitivity of 82% and specificity of 73% (AUC: 0.836; 95% CI:0.795-0.877; p < 0.001). This predictiveness of SII was stronger as compared to NLR (0.836 vs. 0.818, p = 0.043) and PLR (0.836 vs. 0.780, p < 0.001).
Conclusion:
SII is an independent predictor of high thrombus burden in patients with STEMI. In addition, SII is superior to NLR and PLR in this regard.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations